Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide and Vinorelbine for Recurrent Brain Metastases
NCT00026494Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jul 2001
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide, vinorelbine in brain metastasis (BM), sponsored by Memorial Sloan Kettering Cancer Center. Started Jul 2001; status: completed.
02
Drugs
temozolomidevinorelbine
03
Conditions
brain metastasis (BM)
Beyond the preview
Go deeper on NCT00026494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00026494.